Hadasit Bio-Holdings Ltd. is a publicly traded subsidiary (OTCBB: HADSY) of the Hadassah University Hospital, Israel's foremost medical research center, promoting medical breakthroughs. HadasitBio focuses on supporting its portfolio companies as they advance towards Phase II clinical trials and general assistance including pre-clinical trials, manufacturing, regulatory and business development tasks.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions